Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Returns
Return on equity-187.2%-18.0pp-169.2%
Return on assets-139.5%-12.5pp-127%+69.3pp-196.3%-60.3pp-136%+76.8pp-212.9%-34.6pp
Efficiency
Asset turnover
Liquidity
Current ratio1.2×+0.4×0.8×+0.4×0.4×-0.4×0.8×-2.2×-0.7×
Quick ratio1.2×+0.4×0.8×+0.4×0.4×-0.4×0.8×-2.2×-0.7×
Cash ratio+0.4×0.6×+0.3×0.3×-0.3×0.6×-0.7×1.3×-1.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$0.39-11.5%$0.44+31.9%$0.33-24.1%$0.44+92.2%$0.23-71.0%
Valuation
Market capitalization$155.39M+45.8%$42.74M-66.3%$126.74M+23.5%$102.65M-24.9%$136.7M-21.0%
Enterprise value$149.54M+52.3%$39.62M-68.1%$124.12M+31.7%$94.26M-27.8%$130.64M-18.6%
Price / book6.7×+1.2×-5.5×7.6×+2.3×5.3×-8.6×13.9×+2.0×
Free cash flow yield-17.6%-1.8pp-64.8%-45.3pp-19.5%-3.1pp-16.4%-6.3pp-10.1%-1.6pp
Earnings yield-19.9%+6.1pp-70.3%-47.2pp-23.1%+3.9pp-27%-9.9pp-17.2%-4.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do TuHURA Biosciences, Inc.'s ratios come from?
Every ratio is computed from TuHURA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.